Laurie Toich, Associate Editor

Genetic sequencing of joint biopsies may identify which patients with rheumatoid arthritis may respond to therapy.

Nintedanib (Ofev) is currently indicated to slow disease progression among patients with idiopathic pulmonary fibrosis.

AbbVie will not seek accelerated approval of Rovalpituzumab Tesirine as a third-line therapy for small cell lung cancer.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Nilotinib (Tasigna) was previously granted priority review for the treatment of pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia.

Daily doses of sildenafil (Viagra) cut the development of polyps by 50% in mouse models.

Black patients may be eligible for a shorter course of hepatitis C virus treatment.

Biologic drug cannakinumab found to reduce the risk of cardiovascular adverse events among patients with comorbidities.

Individuals who experience high sun exposure during childhood or young adulthood may be less likely to develop multiple sclerosis.

A cellular process could be key to lowering levels of the Huntington disease protein.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Tildrakizumab-asmn (Ilumya) approved for the treatment of moderate-to-severe plaque psoriasis.

The addition of atezolizumab (Tecentriq) to chemotherapy may improve outcomes for patients with advanced non-small cell lung cancer.

A PET scan could quickly indicate whether EGRF-targeted therapy would be beneficial to patients with non-small cell lung cancer.

Adding tenofovir disoproxil fumarate to prevention regimens may not effectively stop hepatitis B virus transmission to infants.

Standard colorectal cancer screening guidelines may not accurately assess risks in certain patients.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Brentuximab vedotin (Adcetris) plus chemotherapy may lead to better disease outcomes for patients with classical Hodgkin lymphoma.

Brentuximab vedotin (Adcetris) plus chemotherapy may lead to better disease outcomes for patients with classical Hodgkin lymphoma.

American Medical Association survey shows need for reform of the prior authorization process.

Lisinopril or carvedilol may protect breast cancer patients from experiencing a decline in heart function.

Tobacco may not be to blame for aggressive oral cancers, a new study suggests.

Idebenone was not found to delay disease progression in multiple sclerosis compared with placebo.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

A popular sweetener could result in bacterial overgrowth and symptom worsening among patients with Crohn disease.

Pan-fibroblast growth factor receptor tyrosine kinase inhibitor demonstrates efficacy in urothelial cancer.